You Should Watch These: Peoples Financial Services (NASDAQ:PFIS), Crawford (NYSE:CRD-B), Johnson & Johnson (NYSE:JNJ), StemCells Inc. (NASDAQ:STEM), KaloBios Pharmaceuticals (NASDAQ:KBIO)


Peoples Financial Services Corp. (NASDAQ:PFIS) on 21 July, reported unaudited financial results at and for the three and six months ended June 30, 2015. Peoples reported net income of$4.4 million, or $0.59 per basic and diluted weighted average share for the second quarter of 2015, compared to $3.3 million, or $0.44 per share, for the comparable period of 2014. Peoples Financial Services Corp. (NASDAQ:PFIS) shares decreased -0.05% in last trading session and ended the day at $39.94. PFIS has a return on assets of 1.10%. Peoples Financial Services Corp. (NASDAQ:PFIS) quarterly performance is -2.97%.

n 23 July, Crawford & Company (NYSE:CRD-B) has named Dan Daniel as vice president, U.S. Property & Casualty client development. He formerly served as vice president of Catastrophe Services for U.S. Property & Casualty for the company. Crawford & Company (NYSE:CRD-B) caters to the Financial space. It has a net profit margin of 2.20% and weekly performance is -8.75%. On the last day of trading company shares ended up $7.40. Crawford & Company (NYSE:CRD-B) distance from 50-day simple moving average (SMA50) is -7.61%.

Johnson & Johnson (NYSE:JNJ) announced that its Board of Directors has declared a cash dividend for the third quarter of 2015 of $0.75 per share on the company’s common stock. The dividend is payable on September 8, 2015 to shareholders of record at the close of business on August 25, 2015. Johnson & Johnson (NYSE:JNJ) shares decreased -0.88% in last trading session and ended the day at $98.28. JNJ Gross Margin is 69.50% and its has a return on assets of 12.00%. Johnson & Johnson (NYSE:JNJ) quarterly performance is -1.57%.

StemCells, Inc. (NASDAQ:STEM) announced that the company’s patent infringement case, StemCells, Inc. v. Neuralstem, Inc., has been dismissed by the US Federal District Court for the District of Maryland for lack of standing. StemCells Inc. (NASDAQ:STEM) shares fell -3.67% in last trading session and ended the day at $0.44. STEM Gross Margin is 90.00% and its has a return on assets of -183.00%. StemCells Inc. (NASDAQ:STEM) quarterly performance is -26.15%.

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO) was downgraded by Zacks from a “buy” rating to a “hold” rating in a report released. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) caters to the Healthcare space. Its weekly performance is -16.36%. On the last day of trading company shares ended up $2.30. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) distance from 50-day simple moving average (SMA50) is -41.34%.


Leave a Reply

Your email address will not be published. Required fields are marked *